AI assistant
Imunon, Inc. — Director's Dealing 2012
Oct 15, 2012
35124_dirs_2012-10-15_ae099b76-ee87-49a1-b0e1-e4f231aeb5b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2012-10-15
Reporting Person: Martinez Alberto R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-10-15 | Celsion Corporation Common Stock | M | 34542 | $2.77 | Acquired | 119542 | Direct |
| 2012-10-15 | Celsion Corporation Common Stock | M | 2500 | $2.36 | Acquired | 122042 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-10-15 | Warrants to purchase Celsion Corporation Common Stock | $2.77 | X | 34542 | Disposed | 2017-05-26 | Celsion Corporation Common Stock (34542) | Direct |
| 2012-10-15 | Warrants to purchase Celsion Corporation Common Stock | $2.36 | X | 2500 | Disposed | 2016-12-06 | Celsion Corporation Common Stock (2500) | Direct |
Footnotes
F1: The Director purchased Celsion Corporation Common Stock through the exercise of warrants obtained in the May 2011 PIPE Stock Offering. These warrants were fully exercisable with an exercise price of $2.77 per share. The Director has no immediate intent to sell these newly acquired shares.
F2: The Director purchased Celsion Corporation Common Stock through the exercise of warrants obtained in the December 2011 PIPE Stock Offering. These warrants were fully exercisable with an exercise price of $2.36 per share. The Director has no immediate intent to sell these newly acquired shares.